In a notable shift for investors, Henry Schein, Inc. (HSIC) recently garnered a ‘Buy’ rating from analyst David Larsen of BTIG on June 11, 2026. This recommendation comes with an optimistic price target of $100, suggesting a significant upside from the current trading price of $78.85. As investors weigh this endorsement, the implications for HSIC’s market positioning and future potential are poised to become a focal point for evaluation.
Recent Price Action
Henry Schein’s stock has exhibited a relatively stable trading pattern around the $78.85 mark, reflecting a minor increase of 0.03% during the last trading session. The company’s performance has been characterized by a high of $87.61 over the past year and a low of $34.53, positioning HSIC as a recovering entity within its sector. The stock’s market capitalization stands at approximately $8.99 billion, with a beta of 0.824, indicating a lower volatility relative to the broader market. Notably, trading volume recently reached 447,135 shares against an average of 1.36 million, further highlighting a cautious yet persistent investor interest in HSIC shares.
Historical Performance
HSIC has demonstrated several interesting trends over the previous periods. Over the past 30 days, the stock has delivered a modest return of 1.46%, while the quarterly performance has been much more robust at 23.42%. Year-to-date, the stock has maintained an 8.33% increase. This upward trajectory is complemented by a weekly volatility of 2.89%, which raises slight concerns but reflects the stock’s ability to rebound. The average trading volume has hovered around 1.38 million shares over the last ten days, with a consistent three-month average of 1.38 million, indicating steady liquidity and investor engagement.
Earnings Analysis
Earnings performance further underscores the positive sentiment toward HSIC. Recently reported earnings per share (EPS) stood at $1.32, surpassing market expectations of $1.20 by a commendable 10%. This marks a continuation of a favorable earnings trend, following a previous EPS of $1.34 which also exceeded estimates. The ability to consistently meet or exceed earnings projections casts HSIC in a favorable light, reinforcing the underlying strength of the company’s financial health.
Analyst Consensus View
The consensus among analysts echoes a growing optimism regarding HSIC’s future. With a total of six ratings compiled over the past 90 days, analysts assigned three ‘Buy’ ratings, two ‘Hold’ ratings, and one ‘Sell’ rating. The average price target has settled at approximately $86.83, with predictions ranging from a low of $64 to a high of $100. This distribution of ratings aligns well with the recent upgrade from BTIG, clearly suggesting that market participants generally anticipate a price rally in the coming months.
Stock Grading or Fundamental View
The Stocks Telegraph Score for Henry Schein, Inc. stands at 48, a metric that captures the overall health and investment profile of the company. While the score indicates room for improvement, it also reflects a solid foundation based on financial and market analysis. The moderate score can be interpreted as a signal for investors: HSIC embodies strong fundamentals and demonstrates promise in innovation within the health care sector, making it one to watch for future developments.
Conclusion
For investors seeking exposure in the health care sector, Henry Schein, Inc. presents a compelling opportunity, particularly for those leaning towards growth-oriented strategies. The recent ‘Buy’ rating and the bullish price target showcased by analysts suggest HSIC is well-positioned for potential gains. However, it is essential for investors to consider the inherent risks, including market volatility and the stock’s historical performance fluctuations. The positive earnings surprise, combined with a generally favorable analyst sentiment, adds to the stock’s allure, marking it as a candidate for those looking for both defensive positions and growth potential in their portfolios.